Journal:PMC:1
From Proteopedia
(Difference between revisions)

Line 25: | Line 25: | ||
'''Proposition #5. The first 3 amino acid sequences of β-endorphin (l-Tyr-Gly-Gly) and the active opioid dipeptide, l-Tyr-Pro, (as a result of a peptide turn and zwitterion bonding) form a virtual piperazine-like ring which is similar in size, shape and location to the heterocyclic rings of morphine, meperidine, and methadone.''' | '''Proposition #5. The first 3 amino acid sequences of β-endorphin (l-Tyr-Gly-Gly) and the active opioid dipeptide, l-Tyr-Pro, (as a result of a peptide turn and zwitterion bonding) form a virtual piperazine-like ring which is similar in size, shape and location to the heterocyclic rings of morphine, meperidine, and methadone.''' | ||
<scene name='Journal:PMC:1/Cv4/2'>Tyr-Gly-Gly- is the N terminus amino acid sequence of beta-endorphin.</scene> However, many apparently dissimilar, di, tri, tetra, penta, and polypeptides are known to have opioid activity, the smallest being l-Tyr-Pro. Within the peptide turn of <scene name='Journal:PMC:1/Cv4/3'>Tyr-Gly-Gly an ionic bond and virtual heterocyclic ring exists formed by the intramolecular zwitterion attraction of the negative carbonyl oxygen to the positively charged nitrogen of tyrosine.</scene> This piperazine-like ring of Tyr-Gly-Gly and piperidine ring of morphine have similar conformations. Tyr-Pro is the minimal length peptide which has been shown to possess opioid | <scene name='Journal:PMC:1/Cv4/2'>Tyr-Gly-Gly- is the N terminus amino acid sequence of beta-endorphin.</scene> However, many apparently dissimilar, di, tri, tetra, penta, and polypeptides are known to have opioid activity, the smallest being l-Tyr-Pro. Within the peptide turn of <scene name='Journal:PMC:1/Cv4/3'>Tyr-Gly-Gly an ionic bond and virtual heterocyclic ring exists formed by the intramolecular zwitterion attraction of the negative carbonyl oxygen to the positively charged nitrogen of tyrosine.</scene> This piperazine-like ring of Tyr-Gly-Gly and piperidine ring of morphine have similar conformations. Tyr-Pro is the minimal length peptide which has been shown to possess opioid | ||
- | activity. <scene name='Journal:PMC:1/Cv4/4'>Tyr-Pro can also form a H-bonded virtual ring and peptide turn which is consistent with this proposition.</scene> | + | activity. <scene name='Journal:PMC:1/Cv4/4'>Tyr-Pro can also form a H-bonded virtual ring and peptide turn which is consistent with this proposition.</scene> |
+ | |||
+ | '''Conclusion'''. A unified theory based on the stereochemistry of a common aromatic-heterocyclic relationship in opioid | ||
+ | and opioid peptides is presented. This theory is supported by five propositions which include experimental data derived from the literature and stereochemical observations from the author’s perspective. Some of the support for the propositions explains new relationships about steric hindrance and optical activity of opioids. This theory could be important for future analgesic drug design. | ||
</StructureSection> | </StructureSection> | ||
<references/> | <references/> | ||
__NOEDITSECTION__ | __NOEDITSECTION__ |
Revision as of 14:50, 23 November 2011
|
- ↑ Joel S. Goldberg, Perspectives in Medicinal Chemistry 2010:4 1-10, Stereochemical Basis for a Unified Structure Activity Theory of Aromatic and Heterocyclic Rings in Selected Opioids and Opioid Peptides doi:http://dx.doi.org/10.4137/PMC.S3898
This page complements a publication in scientific journals and is one of the Proteopedia's Interactive 3D Complement pages. For aditional details please see I3DC.